Capabilities
Built for the full arc of evidence — from Phase 2 through Phase 4.
II
Phase 2
Dose-finding, safety, and early efficacy. Skilled in adaptive designs, biomarker-driven enrichment, and PK/PD intensive sampling.
— Experienced Phase 2 Investigators
— Adaptive & Enrichment Study designs
— Intensive PK sampling
III
Phase 3
Pivotal, registration-enabling trials. Built for high enrollment volume without compromising data quality.
— Multi-arm randomized studies
— Central & local lab workflows
— Risk-based monitoring ready
IV
Phase 4
Post-marketing surveillance, real-world evidence, and label-expansion studies in our community population.
— Registry & observational
— PROs and digital endpoints
— Long-term follow-up cohorts
Therapeutic areas
Where we go deep.
Each therapeutic area is overseen by a dedicated principal investigator with extensive experience conducting trials in the indication.
Vaccines
· Influenza, RSV, mRNA platforms
· Adult cohorts
· Healthy volunteer recruitment
Cardiometabolic
· Type 2 diabetes & GLP-1s
· NASH / MASH studies
· Cardiovascular Disease Prevention
Pulmonology
· COPD exacerbation prevention
· Severe & eosinophilic asthma
· Chronic Cough
Metabolic
· Obesity
· Thyroid & adrenal disorders
· Low Testosterone
General Medicine
· Infectious Disease
· Eczema & Psoriasis
· Device Studies
On-site infrastructure
Equipped for the protocols sponsors actually run.
Imaging & Cardiac
12-lead ECG, telemetry, ambulatory BP, spirometry, on-site MRI & CT Scan
Sample Handling
Refrigerated & ambient centrifuges, -20°C and -80°C monitored storage
Pharmacy
Locked, temperature-controlled IP storage with 21 CFR Part 11 logging
Local Laboratory
CLIA-certified local laboratory with same-day results
Regulatory
Central IRB (Advarra, WCG) and local IRB submissions, 1572s in 48h
Quality
Internal QA audits every quarter, audit-ready essential documents